The clinical performance is complex and often involves multi-systemic burden. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in matching the needs of a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for effectiveness and adverse reactions, adapted to timely schemes according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the elevation of PML along with LAC. The platform serves a team of domestic and foreign experts in the field of Chinese international medical services system matching of the nervous system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.